International Journal of Cancer · 1999 · 65 citations · 26 references
MedicineMolecular BiologyOncologyChemotherapyDna RepairMolecular OncologyChemotherapy ResistanceDna DamageDna Double-strand Break RepairDna Repair DefectsDouble-strand Break RepairTherapeutic ResistanceDefective Dna Repair PathwaysDna Repair Pathway RegulationGenetic Alterations In ResistanceImpaired Dna RepairIntrinsic Resistance MechanismsIntrinsic Resistance RegulationMechanismsO6-methylguanine-dna Methyltransferase Repair
Malignant melanoma is well known for its primary unresponsiveness to chemotherapy. The mechanisms conferring this intrinsic resistance are unclear. In this study, we investigated the role of genes involved in DNA repair in a panel of human melanoma cell variants exhibiting low and high levels of resistance to 4 commonly used drugs in melanoma treatment, i.e., vindesine, etoposide, fotemustine and cisplatin. We show that in melanoma cells exhibiting resistance to cisplatin, etoposide and vindesine, the nuclear content of each of the DNA mismatch repair (MMR) proteins hMLH1, hMSH2 and hMSH6 was reduced by 30-70%. A decreased expression level of up to 80% of mRNAs encoding hMLH1 and hMSH2 was observed in drug-resistant melanoma cells selected for cisplatin, etoposide and fotemustine, while vindesine-selected cells showed only moderate reduction. In melanoma cells that acquired resistance to fotemustine, the amount of nuclear MMR proteins was nearly unaltered, whereas the activity of O6-methylguanine-DNA methyltransferase (MGMT) was considerably enhanced. Activity of N-methylpurine-DNA glycosylase (MPG) was not significantly altered in any of the drug-resistant melanoma cells. Our data indicate that modulation of both MMR components and MGMT expression level may contribute to the drug-resistant phenotype of melanoma cells.
26
The role of DNA mismatch repair in platinum drug resistance.
Daniel Fink, S Nebel, Stefan Aebi et al. · PubMed · 1996 · 603 citations
Loss of DNA mismatch repair in acquired resistance to cisplatin.
Stefan Aebi, Buran Kurdi-Haidar, Robert T. Gordon et al. · PubMed · 1996 · 504 citations
Life Sciences, Genetics, Oncology +16
Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.
Mary T. Hawn, Asad Umar, John M. Carethers et al. · PubMed · 1995 · 363 citations
Life Sciences, Genetics, Oncology +17
Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage
P Branch, Gabriele Aquilina, Margherita Bignami et al. · Nature · 1993 · 358 citations